Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. About Marinus Pharmaceuticals. Marinus Pharmaceuticals, Inc.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

NORML

AUGUST 26, 2019

So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. And it took extensive, concerted efforts from marijuana law reform organizations like NORML to negotiate with Virginia’s Republican Party to get the program finally running.

Marijuana 213

Marijuana Legalization Programs Oil 213

MMJ Recs

APRIL 1, 2024

Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment. Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Poland’s medical cannabis program. Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

The Cannigma

JUNE 1, 2021

France’s (experimental) medical cannabis program. In March, 2021, France launched a two-year experiment to gauge the effectiveness of a nationwide medical marijuana program and to prepare the ground for future distribution, according to the Health Ministry. Children may be eligible in cases of refractory epilepsy or cancer.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. This can lead to a decreased reliance on pharmaceuticals that may adversely affect patients’ health and overall lifestyle.

Legislation 52

Legislation Law Marijuana Dispensary 52

SpeedWeed

AUGUST 9, 2021

Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. Shutterstock. It modified Law No.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. That is perhaps the biggest lie that is being perpetuated on the Alabama public today.

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Veriheal

JANUARY 15, 2021

So does that mean that there is no access to THC for patients in the country? The Medical Cannabis Access Programme. This legislation outlines the requirements for certain patients to have access to the MCAP. Severe and Treatment-Resistant Refractory Epilepsy. Not exactly. Spasticity Related to Multiple Sclerosis.

Legalization 57

Legalization Therapy Access Legislation 57

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Veriheal

NOVEMBER 10, 2020

The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice. .

Chronic Pain 76

Chronic Pain Pharmaceutical Patients Epilepsy 76

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. There can be a total of 5 Pharmaceutical Processors in the state, one for each Health Service area HSA.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

CannaTech

MARCH 29, 2019

Nearly six months into the new program, however, a scant six patients have been granted the licensure required to use medical cannabis. In a tragic-ironic twist, whilst patients are struggling for access, the country has no shortage of cannabis. .” Why Isn’t the UK’s Domestic Medical Cannabis Program Working?

Chronic Pain 50

Chronic Pain Access Patients Food 50

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon. Notably, 41% of the Cannabis users stopped using opioids altogether.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

JANUARY 24, 2020

Hemp Industry Daily reports…… Another product has been approved for use under Ireland’s Medical Cannabis Access Programme (MCAP). Last year , Ireland’s Minister for Health signed legislation to commence a medical cannabis program that is to operate on a pilot basis for five years.

Oil 59

Oil Epilepsy Conditions Treatment 59

Cannabis Law Report

JANUARY 4, 2022

In addition, the surge in medical marijuana production owing to its increasing demand in the pharmaceutical sector is further propelling overall growth. The increasing prevalence of epilepsy and other sleep disorders is aiding the product adoption thereby, positively contributing to the segment growth. Mgc Pharmaceuticals Ltd.

Legalization 52

Legalization Supply Chain Chronic Pain Sleep 52

Cannabis Law Report

JUNE 22, 2021

TOCC’s lozenges address current limitations of the Texas Compassionate Use Program (CUP). Patients can seek refuge with lozenges, an easy-to-digest option for higher-THC dosages that delivers the same amount of active pharmaceutical ingredient. We remain committed to advancing safe, legal access to this powerful medicine.

Cultivation 66

Cultivation Tincture Patients Digestion 66

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 6, 2019

On a guided tour, Thai media was given access to more than a dozen pharmacists, medical researchers and agricultural specialists who are helping build the Thai medical cannabis industry from scratch. The scientists aim to make life more bearable for people suffering through chemotherapy, epilepsy, multiple sclerosis and chronic pain.

Chronic Pain 40

Chronic Pain Agriculture Oil THC 40

The Cannigma

OCTOBER 20, 2021

The agency does not have an official list of health conditions that are eligible for treatment with medical cannabis, but the doctor is required to provide justification for why conventional pharmaceuticals won’t suffice for the patient, and their assessment of why the patient may benefit from medical cannabis.

Legalization 59

Legalization Decriminalization Patients Medicine 59

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. Executive producer, Michael Schaeffer Omer-Man. Music by Desca. MSO: Wait, hold on.

Supply Chain 120

Supply Chain Patients Access Hemp 120

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Shutterstock). It’s everywhere. An anti-seizure wonder drug.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

SEPTEMBER 22, 2021

If the proposal — which was sponsored by Rules Committee Chairman Bill Rabon (R) — is enacted into law, patients who are diagnosed with a “debilitating medical condition” could legally gain access to medical cannabis in North Carolina. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 111

Legalization Patients Cultivation Legislation 111

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Many patients already have access to CBD products in medical marijuana dispensaries and compassion centers where it is legal.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. I am thrilled to have Patricia, Steve, Julie and Dewey join us to help accelerate our capabilities across these key functions,” said Dr. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JUNE 14, 2019

“I’m proud to establish the medical marijuana advisory committee to help expand patient access, and to advance and modernize policies to move Florida into the future of medical marijuana,” Fried said. It’s a medicine that an overwhelming majority of Floridians came together for, calling for constitutionally guaranteed access.”.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

The Joint Blog

OCTOBER 31, 2020

This card can provide individuals with access to cannabis, which is believed to provide relief or assistance for countless disorders. The first step in getting a medical marijuana card in NY is to make sure you meet the program’s criteria. New York has the most unique program amongst the states. ID card with NYS address.

Marijuana 26

Marijuana Chronic Pain Programs Epilepsy 26

Canna Law Blog

NOVEMBER 16, 2021

This piece of law “ ensures the continued access of medical patients and state medical cannabis programs—that serve millions of Americans with severe conditions such as epilepsy and seizure disorders without disruption to patient access” whereby such products will also be instantly grandfathered into lawful interstate commerce.

DEA 91

DEA Business Banking Food 91

Cannabis Law Report

JUNE 26, 2019

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. Lighting Up Florida’s Medical Marijuana PEOPLE: The Front Lines. Cameron Vance, Ph.D. Eric Stevens.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

Veriheal

NOVEMBER 2, 2020

The Australian Department of Health and parliament have not established a list of qualifying conditions, but are currently looking into research for conditions commonly treated with cannabis such as chronic pain, epilepsy, and multiple sclerosis amongst others. More on the Multi-Million Dollar Cannabis Farm in Australia.

Chronic Pain 52

Chronic Pain Strains Conditions Patients 52

Weedistry

JANUARY 30, 2019

Drastic changes to New York’s medical marijuana program are tucked into Gov. These products are also formulated correctly and to what I would call pharmaceutical standards, which is what you want people with compromised immune systems taking into their bodies,” he said. Andrew Cuomo’s plan to legalize recreational pot.

Recreational 40

Recreational Marijuana Legislation Patients 40

SMPL

MAY 26, 2020

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52